1 / 10

Minority Affairs Committee

Guidance for Transplant Program Participation in the Transplantation of Non-A 1 /Non-A 1 B (A 2 /A 2 B) Donor Kidneys into Blood Group B Candidates. Minority Affairs Committee. What problem will the proposal solve?.

charlestyler
Télécharger la présentation

Minority Affairs Committee

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Guidance for Transplant Program Participation in the Transplantation of Non-A1/Non-A1B (A2/A2B) Donor Kidneys into Blood Group B Candidates Minority Affairs Committee

  2. What problem will the proposal solve? • Transplant programs are unsure how to participate in KAS provision that will increase blood type B matches • Post-KAS implementation this provision has not reached full potential

  3. What are the proposed solutions? Guidance created by a workgroup of Minority Affairs, Kidney, and the Transplant Administrators Committee members to create program best practices including: • Suggested titer thresholds • How to develop informed consent policy • How to determine and maintain patient eligibility

  4. What are the proposed solutions?

  5. How will members implement this proposal? • Kidney programs should consider this guidance if they choose perform transplantsof non-A1/non-A1B (A2/A2B) donor kidneys into blood group B candidates • Guidelines are voluntary and not prescriptive of clinical practice

  6. How will the OPTN implement this proposal? • Anticipated Board of Directors Review: Dec. 2017 • If approved, resource available on OPTN website and Transplant Pro • Complementary instructional program, highlighting established programs successfully performing these transplants, will be developed

  7. Questions? Sylvia Rosas, MD, MSCE Minority Affairs Committee Chair Sylvia.Rosas@joslin.harvard.edu Emily Ward, MPA Minority Affairs Committee Liaison Emily.Ward@unos.org

  8. Extra Slides

  9. Supporting Evidence: Selected 2016 MAC Survey Results Figure 1: Which of the following could help you establish an A2/A2B into B blood type protocol at your center?

  10. Guidance Summary Chart: Non-A1/non-A1B (A2/A2B) Protocol Development Recommendations

More Related